From Suspects to the Spitterati: A collision of power, profit, and privacy
By Jessica Cussins
| 06. 27. 2013
DNA is the ultimate big-data dream. It can shed light on our health, ancestry, and family members. It can be used to solve crimes and exonerate the innocent, investigate diseases and treatments, advance basic scientific knowledge, and reveal certain aspects of our histories and potential futures.
But as genetic data is collected and used in increasingly varied contexts, issues of privacy, rights, access, justice, and innovation are poised to collide – and to intersect our lives in both positive and negative ways. The questions raised by this coming collision won’t be answered immediately, but we need to start now to tease out their complexities.
Many suitors are lining up to exploit the explosion of genetic information.
- Local police agencies are creating their own databases – some call them “rogue” databases – and the Supreme Court recently determined that state and federal authorities can take DNA from people arrested (pre-conviction) for serious crimes.
- Companies are rushing to patent genetic findings, even when such claims are absurd (and now, at least partially, ruled unconstitutional by the Supreme Court).
- Marketing and advertising gurus...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...